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Adrenal Myelolipoma:
Operative Indications and Outcomes
Victoria M. Gershuni, MS, James G. Bittner IV, MD, Jeffrey F. Moley, MD, and L. Michael Brunt, MD
Abstract
Background: Adrenal myelolipoma (AM) is a benign lesion for which adrenalectomy is infrequently indicated.
We investigated operative indications and outcomes for AM in a large single-institution series.
Subjects and Methods: A retrospective cohort study of prospectively collected data was conducted. Patients (q16
years of age) who underwent adrenalectomy in the Division of General Surgery at Barnes-Jewish Hospital (1993–
2010) were grouped by operative indication (myelolipoma versus other pathology) and compared using non-
parametric tests (a < 0.05).
Results: Sixteen patients (4.0%) had myelolipomas resected out of 402 patients who underwent adrenalectomy.
Fourteen patients with suspected AM underwent adrenalectomy, 13 (93%) of whom had AM confirmed on
pathology. Indications for adrenalectomy were abdominal or flank pain, large tumor size (>8 cm), atypical
radiologic appearance, and/or inferior vena cava compression. Three patients with suspected other adrenal
lesions had AM confirmed on final pathology. Operative approach was laparoscopic in 15 cases and open in 1
case of a 21-cm lesion. Patients who underwent laparoscopic adrenalectomy for AM (n= 15) or other adrenal
pathology (n= 343) were similar with respect to age, gender, American Society of Anesthesiologists classification,
prior abdominal operation, tumor side, operative time, conversion rate, estimated blood loss, intraoperative
complications, hospital length of stay, and 30-day morbidity. However, patients with resected AM had a higher
body mass index (36.5 – 8.1 kg/m2 versus 30.1 – 7.5 kg/m2; P< .01) and a larger preoperative tumor size
(8.4 – 3.0 cm versus 3.1 – 1.7 cm; P < .01).
Conclusions: Laparoscopic adrenalectomy may be appropriate for patients with a presumptive diagnosis of AM
and abdominal or flank pain, large tumor size, and/or uncertain diagnosis after imaging. Outcomes and
morbidity following LA for AM and other adrenal pathology appear comparable.
Background
Adrenalmyelolipoma (AM) is a benign tumor of matureadipose and variable amounts of hematopoietic tissues.
The majority of AM cases are found incidentally by imaging
studies performed for other reasons or at autopsy and are
recognizable by the detection of macroscopic fat within ad-
renal tissue.1 According to Olsson et al.,2 the incidence of
myelolipoma at autopsy ranges from 0.08% to 0.4%. Males
and females are affected equally, and the peak age range at
diagnosis is between 50 and 70 years of age.3 Although most
AMs are small and asymptomatic, larger tumors may present
with symptoms ranging from nonspecific abdominal pain to
spontaneous retroperitoneal hemorrhage. On imaging, mye-
lolipomatous lesions tend to fall into one of three clinico-
pathologic patterns: (1) isolated AMs, (2) myelolipoma with
hemorrhage (mean diameter, >10 cm), and (3) myelolipoma-
tous foci within other adrenal pathologic conditions.3 Rarely,
myelolipomas have also been reported in extra-adrenal sites.
Computed tomography (CT) imaging studies show macro-
scopic fat and calcification with heterogeneous echogenicity
due to a nonuniform architecture. Typically, asymptomatic
nonhemorrhagic AMs do not require therapy, and surgical
excision is only used for symptomatic lesions or those with
atypical features or if the diagnosis is unclear.4
Few studies have looked specifically at the indications for
surgery for AM. Moreover, this lesion is often underappreci-
ated as a source of adrenal incidentaloma and may be mis-
diagnosed as a potentially malignant adrenal lesion. The
purpose of this study was to review our series of patients with
AM who required surgical intervention and to establish the
indications for surgery, appropriateness of a laparoscopic
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A prospectively maintained registry of all patients who
underwent adrenalectomy by the authors was reviewed.
From 1993 to 2010, 422 adrenalectomies were performed on
402 patients by surgeons in the Sections of Minimally Invasive
Surgery, Endocrine and Oncologic Surgery, and Hepatobili-
ary-Pancreatic and Gastrointestinal Surgery at Washington
University School of Medicine/Barnes-Jewish Hospital (St.
Louis, MO), the overall outcomes of which as a group have
been previously reported.5 Of 402 cases, 16 patients (4%)
underwent adrenalectomy for AM confirmed on final pa-
thology. Data were prospectively collected and used for ret-
rospective cohort analysis under Institutional Review Board
approval. Patient characteristics, perioperative variables, and
operative approach were recorded.
Variables
Preoperative variables included patient age, gender, body
mass index (BMI), American Society of Anesthesiologists
score, history of prior abdominal operations, side of the lesion,
radiographic tumor size (maximum diameter), tumor func-
tioning status as determined by biochemical evaluation, and
indication for operation. Intraoperative variables were total
operative time, estimated blood loss, transfusion requirement,
ultrasound use, and complications. Postoperative variables
were recorded for the period immediately following surgery
and up to the 30-day follow-up; they included specimen size,
gross and surgical pathology, need for transfusion, hospital
length of stay, complication frequency and severity, and
overall morbidity and mortality.
Analysis
Patients who underwent laparoscopic adrenalectomy (LA)
for AM or other adrenal pathology were compared for differ-
ences in characteristics, operative indications, perioperative
outcome, and morbidity using nonparametric tests (a= 0.05).
Results
Over the study time period, 16 patients with AM under-
went adrenalectomy. Indications for adrenalectomy included
abdominal or flank pain (44%), tumor diameter > 8 cm (50%),
atypical radiographic appearance (31%), and inferior vena
cava compression (7%) as shown in Table 1. Six cases had
multiple indications (38%). Preoperatively, the diagnosis was
suspected myelolipoma in all but 3 cases. On imaging, the
AMs ranged in size from 2.8 cm to 30 cm, with a mean size of
9.6 – 6.2 cm. CT was used to identify 12 of the 16 lesions, and
magnetic resonance imaging identified the remaining 4 cases.
The typical radiologic and gross appearances of AM are
shown in Figures 1 and 2. The presence of macroscopic fat,
which is diagnostic of this lesion, is seen in Figure 1B (arrows).
Of the 16 cases, 15 were operated on with a laparoscopic
technique, including one 15-cm lesion that was removed in a
laparoscopic hand-assist fashion. A large left retroperitoneal
lesion that measured 30 cm on preoperative imaging and was
suspected to be a liposarcoma was removed via an open
procedure with en bloc resection of the mass with concomitant
nephrectomy, splenectomy, and distal pancreatectomy. Final
pathology revealed a 21-cm myelolipoma. The mean patient
age was 54 years, with a range of 33 to 76 years. Mean BMI
was 35.2 – 6.1 kg/m2, putting the majority of patients in the
obese category, which corresponds to previous case reports.
Nine were left-sided AM, and 7 were right-sided. Patients
Table 1. Indications for Adrenalectomy
Number of patients
(total n = 16)
Abdominal or flank pain 7 (44%)
Tumor diameter greater than 8 cm 8 (50%)
Atypical radiologic appearance 5 (31%)
IVC compression 1 (7%)
Multiple indications 6 (38%)
IVC, inferior vena cava.
FIG. 1. Radiographic computed tomography appearance of
left adrenal myelolipomas: (A) a 15-cm myelolipoma with
large areas of fat density material (arrows) and (B) a 5.5-cm
myelolipoma with several areas of low attenuation (arrows),
which represent macroscopic fat.
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who underwent LA for AM (n = 15) were statistically similar
to those who underwent LA for other adrenal pathology
(n = 343) with respect to demographics and operative out-
comes as shown in Table 2. There was no difference in gender
between the two groups (62% versus 54% female), side of the
lesion (54% versus 52% left), prior abdominal surgery (46%
versus 46%), or American Society of Anesthesiologists clas-
sification (2.2 – 0.4 versus 2.5 – 0.6). Compared with patients
with other adrenal pathology, patients with AM had a higher
BMI (36.5– 8.1 kg/m2 versus 30.1– 7.5 kg/m2; P < .01) and a
larger preoperative tumor size (8.4– 3.0 cm versus 3.1– 1.7 cm;
P< .01). Six of the 13 patients (46%) in whom the BMI was
recorded had BMI valuesq39 kg/m2.
No intraoperative complications occurred in these patients.
In only 1 case was intraoperative ultrasound used. The aver-
age length of stay was 1.7 days. One patient experienced
postoperative hypotension that required intensive care unit
observation and transfusion of 1 unit of blood but no further
intervention. Length of follow-up ranged from 14 to 213 days,
and no complications occurred during follow-up.
Discussion
AM is an uncommon lesion that consists of macroscopic fat
and hematopoietic precursor cells. It has been proposed that
formation of AM may be precipitated by adrenocortical
metaplasia of the reticuloendothelial cells of blood capillaries
secondary to infection, stress, or necrosis.3,6,7 Most often, they
present as ‘‘incidentalomas’’ on imaging obtained for other
reasons. Typically, they are unilateral, but bilateral AMs are
occasionally seen.8,9 Various imaging modalities are available
for detection of AM, including ultrasound, CT, and magnetic
resonance imaging. The appearance of AMs is variable be-
cause of their heterogeneous composition and presence of fat
and myeloid precursors. The majority of AMs do not re-
quire treatment; however, large size, possible symptoms, or
atypical radiologic appearance merits consideration for
adrenalectomy.
The true incidence of myelolipomas of the adrenal has not
been systematically analyzed, but recent series place the fre-
quency as high as 10%–15% of incidentally discovered adre-
nal masses.10 In our own practice, we have seen increasing
numbers of these lesions over the last several years, in part
because of their relatively large size compared with other
adrenal incidentalomas and because of uncertainty about the
diagnosis. They are therefore more likely to be referred for
surgical evaluation than smaller, benign-appearing cortical
adenomas. Indeed, many of the patients referred to us who
prove to have a myelolipoma have radiologic reports from
outside our institution that describe a ‘‘large adrenal mass
concerning for malignancy’’ or similar verbiage with no
mention of myelolipoma in the differential diagnosis. There-
fore, greater awareness and recognition of AM by primary
physicians, radiologists, and surgeons are needed in order to
reassure patients and avoid unnecessary adrenalectomy.
Few reports exist of surgical series of adrenalectomy for
myelolipoma beyond small case series. In a study of patho-
logic cases from both surgical and postmortem files over a
FIG. 2. (A) Intact and (B) cut gross appearance of a large
adrenal myelolipoma.









Age (years) 51– 8.7 49.4 – 14.6
Female 62% 54%
BMI (kg/m2) 36.5 – 8.1a 30.1 – 7.5a




Side of lesion (left) 54% 52%
Preoperative tumor
size (cm) (range)
8.4 – 3 (2.5–21)a 3.1 – 1.7 (0.2–17.5)a
Operative outcomes
Operative time 160 – 64.6 159– 69







Length of stay (days) 1.7 – 0.9 2.6 – 2.2
30-day morbidity 6.7% 11%
Data are mean– standard deviation values.
aIndicates statistically significant difference (P< .01).
ASA, American Society of Anesthesiologists; BMI, body mass
index.
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30-year period, Lam and Lo11 identified 20 patients with ad-
renal lipomatous tumors, 11 of which were myelolipomas.
Only one malignant tumor was present in this group, which
was an 18-cm liposarcoma, which represented 2.6% of pri-
mary adrenal tumors in their series. Of the myelolipomas,
mean tumor size was 4.3 cm, and the largest AM measured
14.5 cm. Daneshmand and Quek10 reviewed the published
literature on AM and recommended removal of lesions > 7 cm
in diameter because of the risk of rupture, although this re-
mains a rare event. The natural history was studied by Han
et al.,4 who followed up 12 patients with serial imaging over
3.2 years; tumor size remained stable in 5 cases, decreased in 2
cases, and increased in 6 (from a mean size of 5.1 cm to 5.6 cm).
AM is principally a radiographic diagnosis, with the hall-
mark features being a heterogeneous density with the pres-
ence of macroscopic fat as shown in Figure 1. This feature is in
contrast with cortical adenomas in which the fat is intracel-
lular and which results in a homogeneous low attenuation
appearance (<10 Hounsfield units) on noncontrast CT imag-
ing. Because most myelolipomas are referred after CT scan-
ning done for other reasons, magnetic resonance imaging may
be useful in delineating the diagnosis for cases in which the
imaging appearance is unclear. Adrenalectomy is indicated
for patients with pain-related symptoms, large size, or an
atypical appearance on imaging. In our series, the indications
for adrenalectomy were most commonly ipsilateral abdomi-
nal or flank pain, large tumor size (defined as > 8 cm), or an
atypical radiographic appearance that made the diagnosis
uncertain. Six patients had more than one of these indications.
None of the patients had had an acute hemorrhagic event.
Although such cases have been reported in the literature,12 we
have not recommended surgery for asymptomatic patients
unless the imaging diagnosis is unclear.
What should be the approach to the patient with myeloli-
poma once the radiographic diagnosis is clear? Our group
would generally recommend at a minimum biochemical
screening with fractionated plasma metanephrines to exclude
a pheochromocytoma. This step insures that this diagnosis is
not considered further; it also is performed because preanes-
thetic pheochromocytoma exclusion is obligatory for any fu-
ture non–adrenal-related surgical procedure. Whether these
patients should be screened for cortisol dysfunction is de-
batable. Isolated reports of associated hypersecretion of ad-
renal hormones has been observed,14–16 but such secretion
may be due to the coexistence of a cortical adenoma or
pheochromocytoma in addition to the AM.10 Our approach
has been to screen with an overnight dexamethasone test only
in cases in which there may be clinical suspicion of clinical or
subclinical Cushing’s syndrome.13 For small myelolipomas
no further imaging or testing should be indicated. For AMs
5 cm or larger, one follow-up scan (usually non-contrast ad-
renal CT) is done at 6–12 months, and if the lesion is stable, no
further testing is recommended.
Our series is the first series of this size to report outcomes of
LA for AM and the first to compare outcomes with other
adrenal tumors. Despite their large size, myelolipomas can
usually be removed laparoscopically because they are well
encapsulated, are easily mobilized from the surrounding
retroperitoneum, and have virtually no risk of recurrence. If a
primary adrenal cortical malignancy is suspected, then the
same criteria for open versus laparoscopic should be used (i.e.,
size < 7 cm, lack of invasiveness and high level of surgeon
experience). The largest AM removed in our series was 21 cm
and was approached with an open procedure with en bloc
resection of surrounding organs because of the suspicion of a
liposarcoma. A 15-cm myelolipoma in a patient with bilateral
AMs was removed in a laparoscopic hand-assisted approach.
None of the cases was converted to an open procedure, and no
patient experienced an intraoperative complication.
Recently, Shen et al.16 reported 8 patients with AM who
were treated by retroperitoneal laparoscopic liposuction.
Mean tumor size was 10.5 cm and ranged from 8 to 14 cm.
Their technique involved making a 1-cm incision on the
membrane surface of the AM, suctioning out the lesion under
routine suction pressure, and then closing the membrane with
a clip. Although no recurrence was observed over 8–77
months of follow-up, no mention was made of whether any
residual AM tissue could be seen on follow-up imaging.
Whether this technique will have a future role in the surgical
approach to AM should await studies in larger numbers of
patients with longer follow-up.
A potentially interesting observation in our AM patients is
the incidence of obesity. Mean BMI was 36 kg/m2, and most
patients were obese; 6 of 13 patients for whom BMI data were
available had BMI values > 39 kg/m2. These BMI values were
also significantly higher than for the rest of our adrenalectomy
population. Because fat is a major component of AM, this
raises the question of whether AM may be seen more com-
monly in the era of the obesity epidemic.
In summary, we report one of the largest series of AMs
treated surgically to date. Indications for surgery most often
include large size, local symptoms of pain, or atypical imag-
ing appearance and uncertainty of the diagnosis. LA results in
good outcomes and should be the preferred approach for the
select group of AM patients in whom surgical resection is
indicated.
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